Company profile

Ambulero company profile

Ambulero, Inc is a cell and gene therapy spin-out of the University of Miami focused on advancing new therapies to fight vascular disease.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Revenue range
$1K+
Founded
2019-01-01

Headquarters

Headquarters
Hazel Green, Alabama, United States
Postal code
33136
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$5.5M
Last funding
Seed / $5.5M / 2021-01-25
Last equity funding
Seed / $5.5M
Investors
1
Lead investors
1
Founders
4
Articles
4

Founders and investors

Founders

Omaida VelazquezRandy BerholtzRobert BuchananZhao-Jun Liu

Lead investors

Orphinic Scientific

Investors

Orphinic Scientific

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.